Article Details
Retrieved on: 2022-09-28 08:23:17
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AQR Capital Management LLC bought a new position in Spero Therapeutics in the 2nd quarter worth about $115,000. Finally, Assenagon Asset Management ...
Article found on: reporter.am
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here